-transparent.png){kind=logo}
Zidovudine (azidothymidine, AZT) disposition was examined during a hemodialysis session in an HIV-infected male with mesangial proliferative glomerulonephritis. Serum concentrations of zidovudine and its glucuronidated inactive metabolite (G-ZDV) were measured by HPLC. Zidovudine pharmacokinetics were similar to previous reports in patients with normal renal function, however, G-ZDV concentrations were significantly elevated (23-440 times zidovudine concentration). Hemodialysis did not appreciably reduce zidovudine or G-ZDV levels. Significance of chronically elevated G-ZDV levels is unknown.
Related Publications
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
August 1988,
The American journal of medicine,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
October 1988,
Archives of dermatology,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
January 1990,
Journal of the American Academy of Dermatology,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
January 1990,
Archives of dermatology,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
October 1988,
Annals of internal medicine,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
June 1989,
Archives of internal medicine,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
February 1989,
Mycopathologia,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
June 2004,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
March 1983,
Annals of internal medicine,
T A Tartaglione, and
E Holeman, and
K Opheim, and
T Smith, and
A C Collier
September 1995,
Cutis,
